Details of the Drug Formulations

General Information of Drug (ID: DMGO2MC)

Drug Name

FENOFIBRIC ACID Drug Info

Synonyms

Fenofibric acid; 42017-89-0; Procetofenic acid; 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid; alpha 1081; NSC 281318; LF 178 acid; UNII-BGF9MN2HU1; 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid; LF 153; FNF Acid; C17H15ClO4; Trilipix; CCRIS 7302; EINECS 255-626-9; BGF9MN2HU1; CHEMBL981; BRN 2058973; CHEBI:83469; 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid; Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-; AK117112; 2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoic acid; W-106287

Indication

Disease Entry	ICD 11	Status	REF
Cardiovascular disease	BA00-BE2Z	Approved	[1]

Cross-matching ID

PubChem CID: 64929
ChEBI ID: CHEBI:83469
CAS Number: 42017-89-0
TTD ID: D0NF1U
VARIDT ID: DR00651
INTEDE ID: DR2500
ACDINA ID: D00269

Full List of Drug Formulations Containing This Drug

Fenofibric acid 45 mg capsule

Company	Formulation ID	FDA Description
Par Pharmaceutical	F08082	Stearic acid; Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Gelatin; Hydroxypropyl cellulose (type m); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac
Mylan Pharamceuticals	F08084	Sodium lauryl sulfate; Sodium stearyl fumarate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type h); Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Povidones; Shellac
Mylan Pharamceuticals	F08085	Sodium lauryl sulfate; Sodium stearyl fumarate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type h); Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Povidones; Shellac
Lupin Pharmaceuticals	F08080	Lactose monohydrate; Sodium lauryl sulfate; Sodium stearyl fumarate; Dibutyl sebacate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Colloidal silicon dioxide; Ethylcelluloses; Gelatin; Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Povidone k90; Shellac
Alembic Pharmaceuticals	F08083	Sodium stearyl fumarate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Water; Povidone k30; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type e); Hypromelloses; Methacrylic acid; Shellac
Actavis Pharma	F08079	Sodium lauryl sulfate; Ammonia; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Ammonio methacrylate copolymer type b; Gelatin; Hydroxypropyl cellulose (type l); Shellac; Starch, corn
AbbVie	F08081	Sodium stearyl fumarate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Water; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type h); Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Povidones
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 Formulation(s)

Fenofibric acid 135 mg capsule

Company	Formulation ID	FDA Description
American Health Packaging; Golden State Medical Supply; Par Pharmaceutical	F08072	Stearic acid; Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Gelatin; Hydroxypropyl cellulose (type m); Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac
Mylan Pharamceuticals	F08075	Sodium lauryl sulfate; Sodium stearyl fumarate; Fd&c blue no. 2; Ammonia; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type h); Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Povidones; Shellac
Mylan Pharamceuticals	F08076	Sodium lauryl sulfate; Sodium stearyl fumarate; Fd&c blue no. 2; Ammonia; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type h); Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Povidones; Shellac
Lupin Pharmaceuticals	F08070	Lactose monohydrate; Sodium lauryl sulfate; Sodium stearyl fumarate; Dibutyl sebacate; Fd&c blue no. 1; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Colloidal silicon dioxide; Ethylcelluloses; Gelatin; Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Povidone k90; Shellac
Alembic Pharmaceuticals	F08073	Sodium stearyl fumarate; Fd&c blue no. 2; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Triethyl citrate; Water; Povidone k30; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type e); Hypromelloses; Methacrylic acid; Shellac
Physicians Total Care	F08074	Sodium stearyl fumarate; Fd&c blue no. 2; Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Water; Povidone; Silicon dioxide; Gelatin; Hydroxypropyl cellulose; Hypromelloses
AbbVie	F08071	Sodium stearyl fumarate; Fd&c blue no. 2; Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Water; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type h); Hypromelloses; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Povidones
Actavis Pharma	F08069	Sodium lauryl sulfate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Ammonio methacrylate copolymer type b; Gelatin; Hydroxypropyl cellulose (type l); Shellac; Starch, corn
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Formulation(s)

Fenofibric acid 105 mg tablet

Company	Formulation ID	FDA Description
Aralez Pharmaceuticals; Caraco Pharma; Halton Laboratories; Mutual Pharmaceutical; Tribute Pharmaceuticals	F08067	Magnesium stearate; Crospovidone; Cellulose, microcrystalline; Copovidone k25-31
------------------------------------------------------------------------------------

Fenofibric acid 35 mg tablet

Company	Formulation ID	FDA Description
Aralez Pharmaceuticals; Caraco Pharma; Halton Laboratories; Mutual Pharmaceutical; Tribute Pharmaceuticals	F08077	Magnesium stearate; Crospovidone; Cellulose, microcrystalline; Copovidone k25-31
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2662).